Birgit M Wollmann

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 6

Top Topics

High Resolution Mass Spectrometry

Chronic Kidney Disease

Top Venues

Clinical and translational science

European journal of clinical pharmacology

British journal of clinical pharmacology

This page only lists publications with an associated author ORCID identifier.

Publications

Robert Løvsletten Smith, Birgit M Wollmann, Elisabet Størset, Hasan Çağın Lenk, Kevin Sean O'Connell, Marianne Kristiansen Kringen, Magnus Ingelman-Sundberg, Espen Molden
Effect of the NFIB rs28379954 T>C polymorphism on CYP2D6-catalyzed metabolism of solanidine. Clinical and translational science 17 (2) (2024)
Robert Løvsletten Smith, Birgit M Wollmann, Elisabet Størset, Hasan Çağın Lenk, Kevin Sean O'Connell, Marianne Kristiansen Kringen, Magnus Ingelman-Sundberg, Espen Molden
Effect of the NFIB rs28379954 T>C polymorphism on CYP2D6-catalyzed metabolism of solanidine. Clinical and translational science 17 (2) (2024)
Robert Løvsletten Smith, Birgit M Wollmann, Elisabet Størset, Hasan Çağın Lenk, Kevin Sean O'Connell, Marianne Kristiansen Kringen, Magnus Ingelman-Sundberg, Espen Molden
Effect of the NFIB rs28379954 T>C polymorphism on CYP2D6-catalyzed metabolism of solanidine. Clinical and translational science 17 (2) (2024)
Birgit M Wollmann, Elisabet Størset, Marianne Kristiansen Kringen, Espen Molden, Robert Løvsletten Smith
Prediction of CYP2D6 poor metabolizers by measurements of solanidine and metabolites-a study in 839 patients with known CYP2D6 genotype. European journal of clinical pharmacology (2023)
Birgit M Wollmann, Elisabet Størset, Marianne Kristiansen Kringen, Espen Molden, Robert Løvsletten Smith
Prediction of CYP2D6 poor metabolizers by measurements of solanidine and metabolites-a study in 839 patients with known CYP2D6 genotype. European journal of clinical pharmacology 79 (4) (2023)
Birgit M Wollmann, Robert Løvsletten Smith, Marianne Kristiansen Kringen, Magnus Ingelman-Sundberg, Espen Molden, Elisabet Størset
Evidence for solanidine as a dietary CYP2D6 biomarker: Significant correlation with risperidone metabolism. British journal of clinical pharmacology (2023)